Prediabetes phenotypes: can aetiology and risk profile guide lifestyle strategies for diabetes prevention?
Exploring prediabetes phenotypes: diverse risk profiles and tailored prevention strategies for Type 2 diabetes. π©Ίπ
July 13, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π€ Personalized Medicine.
Bridging Genomics to Cardiology Clinical Practice: Artificial Intelligence in Optimizing Polygenic Risk Scores: A Systematic Review.
AI-Optimized Polygenic Risk Scores Enhance Cardiovascular Disease Prediction: A Systematic Review of 13 Studies πβ€οΈ
June 29, 2025
NHS App to Enhance Mental Health Support with AI Features
NHS App introduces AI features for improved mental health support. Patients can self-refer for therapies anytime. π§ π±
June 27, 2025
Immunomodulatory Therapy in Non-Infectious Uveitis: Current Landscape, Gaps, and Future Directions.
Immunomodulatory therapy for non-infectious uveitis: addressing gaps, optimizing strategies, and future AI advancements. π§ ποΈ
June 26, 2025
The gut virome and human health: From diversity to personalized medicine.
Exploring the gut virome’s role in health: diversity, phage therapies, and precision medicine advancements. π¦ π
June 23, 2025
Seoul National University Hospital Launches AI-Powered Precision Medicine System
Seoul National University Hospital introduces an AI-driven precision medicine system for personalized cancer treatment. π₯π‘
June 16, 2025
New Telemedicine Service for Breast Cancer Prevention Launched in the UK
New telemedicine service for breast cancer prevention launched in the UK. Women 30+ can assess their risk. π©Ίπ
June 10, 2025
Omada Health Begins Trading on Nasdaq at $19 per Share
Omada Health starts trading on Nasdaq at $19 per share, raising $150 million for chronic care management. ππΌ
June 9, 2025
From Acquisition to Prognosis: The Role of AI in Cardiac Magnetic Resonance Imaging Evaluation of Ischemic Cardiomyopathy.
AI enhances cardiac MRI for ischemic cardiomyopathy, improving accuracy and prognosis. Key findings from PubMed article reviewed. π«π
June 9, 2025
Histopathologic deep learning model for predicting tumor response to hepatic arterial infusion chemotherapy plus TKIs and ICIs in large hepatocellular carcinoma.
Deep learning predicts tumor response in large HCC: HTI shows 54.45% ORR vs. 21.65% for HAIC. ππ§¬
June 8, 2025